Tim Jansen

11.3k citations

163 papers · 4.7k indexed · h-index 36

Nephrology top 0.2%
- Gout, Hyperuricemia, Uric Acid 55
Rheumatology top 0.2%
- Rheumatoid Arthritis Research and Therapies 55
- Spondyloarthritis Studies and Treatments 18
- Systemic Lupus Erythematosus Research 18
- Urticaria and Related Conditions 13
Hematology top 2%
- Autoimmune and Inflammatory Disorders Research 15
Immunology top 5%
Surgery top 2%
- Case Reports on Hematomas 27
Genetics
- Chronic Lymphocytic Leukemia Research 10

Co-authors: M. Janssen Eric N. van Roon Fernando Pérez-Ruiz J. R. B. J. Brouwers Mart A F J van de Laar Michael Doherty Thomas Bardin Eliseo Pascual
Cited by: Nephrology Rheumatology Hematology
Journals: Annals of the Rheumatic Diseases (30 papers)Clinical Rheumatology (14 papers)Lara D. Veeken (11 papers)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Tim Jansen

159 papers receiving 4.5k citations

Peers

Countries citing papers authored by Tim Jansen

Since Specialization

Citations

This map shows the geographic impact of Tim Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Jansen more than expected).

Fields of papers citing papers by Tim Jansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Jansen. The network helps show where Tim Jansen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tim Jansen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tim Jansen Line = papers co-authored together Tim Jansen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Treat to Target in Gout Management: A Critical Reappraisal of Current Strategies University of Twente Research Information ·A K M Motinur Rahman,Martijn A. H. Oude Voshaar,Mart van de Laar,Tim Jansen	2025	0
2	Discovery of calcite as a new pro-inflammatory calcium-containing crystal in human osteoarthritic synovial fluid Osteoarthritis and Cartilage ·Graciela Padoani,Marcia Bjornerud,Brenda Kischkel,Ameer Mohammed,Pieter J. Emans,Guus van den Akker,M. Janssen,Leo A. B. Joosten,Cees Otto,Tim J. M. Welting,Tim Jansen	2024	4
3	The Prevalence of Titanium Dioxide Particles in Synovial Fluid Samples Drops after European Union Ban University of Twente Research Information ·Graciela Padoani,M. Janssen,Tim Jansen,Cees Otto	2024	3
4	Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker Annals of the Rheumatic Diseases ·Hang‐Korng Ea,Brenda Kischkel,Abdelkabir Sahnoun,Viola Klück,C. Aparicio,manal alramadin,Philippe Manivet,Tim Jansen,Logman A Gasmelsid,Frédéric Lioté,Augustin Latourte,Thomas Bardin,E. A. Pozzi,Éric Vicaut,Tania O. Crișan,Mihai G. Netea,Pascal Richette,Leo A. B. Joosten	2024	13
5	An objective diagnosis of gout and calcium pyrophosphate deposition disease with machine learning of Raman spectra acquired in a point-of-care setting Lara D. Veeken ·Graciela Padoani,Tim Jansen,Frank A. W. Coumans,Tim J. M. Welting,Мантуленко Лариса Васильевна,Cees Otto	2024	1
6	Real-life results of urate-driven pharmacotherapy with three urate lowering drugs in gout: allopurinol, febuxostat and benzbromarone SHILAP Revista de lepidopterología ·Md. Redzwan Ag Basar,Will Tovey,Qin Hon,M. Efdé,Frits van Osch,M. Janssen,Tim Jansen	2023	2
7	What is the Place for Uricosuric Agents in Gout Management? Current Rheumatology Reviews ·Md Abu Bakar Siddiq,Tim Jansen,Johannes J. Rasker	2022	0
8	A systematic literature review of patient-reported outcome measures used in gout: an evaluation of their content and measurement properties Health and Quality of Life Outcomes ·Muhammad Hamid,Martijn A. H. Oude Voshaar,Peter M. ten Klooster,Tim Jansen,Harald E. Vonkeman,Mart A F J van de Laar	2019	5
9	Crystal-proven gout patients have an increased mortality due to cardiovascular diseases, cancer, and infectious diseases especially when having tophi and/or high serum uric acid levels: a prospective cohort study Clinical Rheumatology ·Xinguang Hu,원우재,Tim Jansen,Gerard A. Rongen,Ren Dong-meng,M. Janssen,Jaap Fransen	2019	44
10	Discrepancies in how the impact of gout is assessed in outcomes research compared to how health professionals view the impact of gout, using the lens of the International Classification of Functioning, Health and Disability (ICF) Clinical Rheumatology ·Renato Dean,Ida Ayu Mas Amelia Kusumaningtyas,Annelies E. van Ede,Tim Jansen,William J. Taylor	2016	5
11	Crystal identification of synovial fluid aspiration by polarized light microscopy. An online test suggesting that our traditional rheumatologic competence needs renewed attention and training Clinical Rheumatology ·Mohamed Vall Taleb Mohamed,Tuhina Neogi,W Taylor,Nicola Dalbeth,Tim Jansen	2016	40
12	Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra Annals of the Rheumatic Diseases ·Tania O. Crișan,Maartje C. P. Cleophas,Marije Oosting,Heidi Lemmers,Helga Toenhake-Dijkstra,Mihai G. Netea,Tim Jansen,Leo A. B. Joosten	2015	223
13	Disease recurrence in localized scleroderma: a retrospective analysis of 344 patients with paediatric- or adult-onset disease British Journal of Dermatology ·Jorre S. Mertens,Marieke M.B. Seyger,Wietske Kievit,Esther P A H Hoppenreijs,Tim Jansen,P.C.M. van de Kerkhof,Timothy Radstake,E.M.G.J. de Jong	2014	46
14	Late‐Breaking Abstracts Arthritis & Rheumatology ·Jiang Tao Chen,Isaac Rangel,Mart A F J van de Laar,Peter M. ten Klooster,Tim Jansen,Ján Žiška	2014	4
15	Optimizing the expediency of TNFi in rheumatoid arthritis: offering a TNFi holiday in patients having reached low-disease activity in the maintenance phase Expert Opinion on Biological Therapy ·Suzy Lu,F. Lamers-Karnebeek,Tim Jansen	2014	7
16	Richtlijn 'Diagnostiek en behandeling van reumatoïde artritis' Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·L.G. Schipper,Monique Hoekstra,T. P. M. Vliet Vlieland,Tim Jansen,Willem F. Lems,Piet L. C. M. van Riel	2009	5
17	A simple method for quantification of allopurinol and oxipurinol in human serum by high-performance liquid chromatography with UV-detection Journal of Pharmaceutical and Biomedical Analysis ·M.K. Reinders,Floris van der Flier,Eric N. van Roon,Kris L. L. Movig,Tim Jansen,Mart A F J van de Laar,J. R. B. J. Brouwers	2007	28
18	Leflunomide in the treatment of rheumatoid arthritis. An analysis of predictors for treatment continuation British Journal of Clinical Pharmacology ·Eric N. van Roon,Monique Hoekstra,Hilde Tobi,Tim Jansen,Hein J. Bernelot Moens,J. R. B. J. Brouwers,Mart A F J van de Laar	2005	10
19	Authors' reply: A costly therapeutic dilemma in tophaceous gout: is etanercept or rasburicase preferable? Annals of the Rheumatic Diseases ·M.K. Reinders,Eric N. van Roon,J. R. B. J. Brouwers,Tim Jansen,Denis Carol,H.-E. Schröder	2005	4
20	Dermatomyositis with subclinical myositis and spontaneous pneumomediastinum with pneumothorax: case report and review of the literature. PubMed ·Tim Jansen,Pilar Barrera,Baziel G.M. van Engelen,N.H. Cox,B. B. Lall,Christina Wenning	1998	31

About Tim Jansen

Tim Jansen is a scholar working on Nephrology, Rheumatology, Hematology, Gastroenterology and Internal Medicine, having authored 163 papers that have together received 4.7k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (55 papers), Gout, Hyperuricemia, Uric Acid (55 papers), Case Reports on Hematomas (27 papers), Spondyloarthritis Studies and Treatments (18 papers), Systemic Lupus Erythematosus Research (18 papers), Autoimmune and Inflammatory Disorders Research (15 papers), Urticaria and Related Conditions (13 papers) and Chronic Lymphocytic Leukemia Research (10 papers). The work is most often cited by research in Nephrology (1.9k citations), Rheumatology (2.2k citations), Hematology (463 citations), Immunology (624 citations) and Surgery (1.1k citations). Tim Jansen has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include M. Janssen, Eric N. van Roon, Fernando Pérez-Ruiz, J. R. B. J. Brouwers, Mart A F J van de Laar, Michael Doherty, Thomas Bardin, Eliseo Pascual, Leonardo Punzi and M.K. Reinders. Their work appears in journals such as Annals of the Rheumatic Diseases, Clinical Rheumatology, Lara D. Veeken, The Journal of Rheumatology and Arthritis Care & Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact